NCT04503512

Brief Summary

Introduction: The infrapatellar fat pad (Hoffa's fat pad) is a structure which is located intra-articularly. Its function is not well known. During knee replacement surgery, some surgeons would prefer removing the whole of the fat pad as this can improve exposure of the knee joint, as it can affect exposure of the knee joint which will in turn make the procedure slightly more efficient. Other surgeons would rather resect the minimum amount and preserve the bulk of the structure as anecdotally this is thought to decrease the level of post operative pain. This surgical step fat pad resection is a very small part of the whole total knee replacement procedure. A previous retrospective review of patients whose fat pad had been removed showed that they were nearly twice as likely to experience postoperative pain (P = 0.0005), while another study showed that they are at a slight risk of patellar tendon shortening. A randomised controlled trial of 68 patients did not show any difference in patella tendon length at six months and no difference in pain relief in both groups 3. However this study did not evaluate the functional outcome in both groups. To our knowledge, there are no RCT looking at the effect of the excision or preservation of the fat pad in TKR and the functional outcomes post operatively. Study Hypothesis: Excision of Hoffa's fat pad during total knee replacement surgery does not affect functional outcome, pain level after surgery or the patella tendon length at either one or two years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
154

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 23, 2012

Completed
6.8 years until next milestone

First Submitted

Initial submission to the registry

August 23, 2019

Completed
12 months until next milestone

First Posted

Study publicly available on registry

August 7, 2020

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

February 15, 2024

Status Verified

June 1, 2023

Enrollment Period

9.9 years

First QC Date

August 23, 2019

Last Update Submit

February 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Koos Knee Score

    The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a knee-specific instrument, developed to assess the patients' opinion about their knee and associated problems. The KOOS evaluates both short-term and long-term consequences of knee injury.

    3 months post op,

Study Arms (2)

Non removal of fat pad

ACTIVE COMPARATOR

Non removal of fat pad

Procedure: non removal of fat pad

Removal of fat pad

ACTIVE COMPARATOR

Removal of fat pad

Procedure: removal of fat pad

Interventions

Removal removal of fat pad

Removal of fat pad

non removal of fat pad

Non removal of fat pad

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary total knee replacement for knee osteoarthritis

You may not qualify if:

  • Revision Surgery.
  • Primary Knee Replacement for pathologies other than Osteoarthritis.
  • Previous knee fractures around the knee.
  • Previous confirmed intra-articular infections.
  • Non English speaking/reading patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Broadgreen Hospital

Liverpool, United Kingdom

Location

Study Officials

  • A Howard

    Liverpool University Hospitals NHS Foundation Trust

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2019

First Posted

August 7, 2020

Study Start

October 23, 2012

Primary Completion

September 1, 2022

Study Completion

September 1, 2022

Last Updated

February 15, 2024

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations